Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
Ariane Sadr-Nabavi, Juliane Ramser, Juliane Volkmann, Joerg Naehrig, Frank Wiesmann, Beate Betz, Heide Hellebrand, Stefanie Engert, Susanne Seitz, Rene Kreutzfeld, Takako Sasaki, Norbert Arnold, RitaТом:
124
Рік:
2009
Мова:
english
Сторінки:
9
DOI:
10.1002/ijc.24108
Файл:
PDF, 707 KB
english, 2009